| Global regulation of virulence and the stress response by CsrA in the highly adapted human gastric pathogen Helicobacter pylori FM Barnard, MF Loughlin, HP Fainberg, MP Messenger, DW Ussery, ... Molecular microbiology 51 (1), 15-32, 2004 | 150 | 2004 |
| The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review IA Cree, L Uttley, H Buckley Woods, H Kikuchi, A Reiman, S Harnan, ... BMC cancer 17, 1-17, 2017 | 119 | 2017 |
| Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection F Collinson, M Hutchinson, RA Craven, DA Cairns, A Zougman, TC Wind, ... Clinical Cancer Research 19 (18), 5227-5239, 2013 | 82 | 2013 |
| Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma SH Sim, MP Messenger, WM Gregory, TC Wind, NS Vasudev, J Cartledge, ... British journal of cancer 107 (7), 1131-1137, 2012 | 80 | 2012 |
| Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual … PAJ Crosbie, R Gabe, I Simmonds, M Kennedy, S Rogerson, N Ahmed, ... BMJ open 10 (9), e037075, 2020 | 63 | 2020 |
| Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation MPW Smith, A Zougman, DA Cairns, M Wilson, T Wind, SL Wood, ... Kidney international 84 (6), 1214-1225, 2013 | 57 | 2013 |
| Evaluating diagnostic strategies for early detection of cancer: the CanTest framework FM Walter, MJ Thompson, I Wellwood, GA Abel, W Hamilton, M Johnson, ... Bmc Cancer 19 (1), 1-11, 2019 | 49 | 2019 |
| A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine RL Kift, MP Messenger, TC Wind, S Hepburn, M Wilson, D Thompson, ... Annals of clinical biochemistry 50 (3), 236-244, 2013 | 47 | 2013 |
| The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation PS Hall, ED Mitchell, AF Smith, DA Cairns, M Messenger, M Hutchinson, ... Health Technology Assessment (NIHR), 2018 | 45 | 2018 |
| Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: evaluation of the performance of three systems for clinical utility B Snaith, MA Harris, B Shinkins, M Jordaan, M Messenger, A Lewington Clinical Chemistry and Laboratory Medicine (CCLM) 56 (8), 1269-1276, 2018 | 39 | 2018 |
| Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences … TC Wind, MP Messenger, D Thompson, PJ Selby, RE Banks Annals of clinical biochemistry 48 (2), 112-120, 2011 | 38 | 2011 |
| Human Recombinant B7-H3 Expressed in E. coli Enhances T Lymphocyte Proliferation and IL-10 Secretion in Vitro GB Zhang, YJ Chen, Q Shi, HB Ma, Y Ge, Q Wang, Z Jiang, Y Xu, ... Acta biochimica et biophysica Sinica 36 (6), 430-436, 2004 | 37 | 2004 |
| Target Product Profiles for medical tests: a systematic review of current methods P Cocco, A Ayaz-Shah, MP Messenger, RM West, B Shinkins BMC medicine 18, 1-12, 2020 | 32 | 2020 |
| Toward a framework for outcome-based analytical performance specifications: a methodology review of indirect methods for evaluating the impact of measurement uncertainty on … AF Smith, B Shinkins, PS Hall, CT Hulme, MP Messenger Clinical chemistry 65 (11), 1363-1374, 2019 | 28 | 2019 |
| European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis G Abignano, J Blagojevic, LA Bissell, RB Dumitru, S Eng, Y Allanore, ... Rheumatology 58 (2), 254-259, 2019 | 27 | 2019 |
| RIPOSTE: a framework for improving the design and analysis of laboratory-based research NGD Masca, EMA Hensor, VR Cornelius, FM Buffa, HM Marriott, JM Eales, ... Elife 4, e05519, 2015 | 25 | 2015 |
| Regenerative medicine: a snapshot of the current regulatory environment and standards. MP Messenger, PE Tomlins Adv. Mater. 23 (12), 2011 | 24 | 2011 |
| Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis. M Stevenson, A Metry, M Messenger Health Technology Assessment (Winchester, England) 25 (39), 1, 2021 | 18 | 2021 |
| Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis. M Stevenson, A Metry, M Messenger Health Technology Assessment (Winchester, England) 25 (21), 1, 2021 | 17 | 2021 |
| Identifying novel biomarkers ready for evaluation in low-prevalence populations for the early detection of upper gastrointestinal cancers: a systematic review N Calanzani, PE Druce, C Snudden, KM Milley, R Boscott, D Behiyat, ... Advances in therapy 38, 793-834, 2021 | 15 | 2021 |
